Catalyst Wire Dossier Catalyst Wire Dossier

Lanreotide microparticles

lanreotide · Ipsen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lanreotide microparticles, covering 2020-11-05 to 2020-11-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis [Phase 3]

See pricing